<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37041143</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Comparative epidemic expansion of SARS-CoV-2 variants Delta and Omicron in the Brazilian State of Amazonas.</ArticleTitle><Pagination><StartPage>2048</StartPage><MedlinePgn>2048</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2048</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-37541-6</ELocationID><Abstract><AbstractText>The SARS-CoV-2 variants of concern (VOCs) Delta and Omicron spread globally during mid and late 2021, respectively. In this study, we compare the dissemination dynamics of these VOCs in the Amazonas state, one of Brazil's most heavily affected regions. We sequenced the virus genome from 4128 patients collected in Amazonas between July 1st, 2021, and January 31st, 2022, and investigated the viral dynamics using a phylodynamic approach. The VOCs Delta and Omicron BA.1 displayed similar patterns of phylogeographic spread but different epidemic dynamics. The replacement of Gamma by Delta was gradual and occurred without an upsurge of COVID-19 cases, while the rise of Omicron BA.1 was extremely fast and fueled a sharp increase in cases. Thus, the dissemination dynamics and population-level impact of new SARS-CoV-2 variants introduced in the Amazonian population after mid-2021, a setting with high levels of acquired immunity, greatly vary according to their viral phenotype.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Arantes</LastName><ForeName>Ighor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bello</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2724-2793</Identifier><AffiliationInfo><Affiliation>Laboratório de AIDS e Imunologia Molecular, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil. gbellobr@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nascimento</LastName><ForeName>Valdinete</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Souza</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Arlesson</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Dejanane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nascimento</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mejía</LastName><ForeName>Matilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandão</LastName><ForeName>Maria Júlia</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonçalves</LastName><ForeName>Luciana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundação de Vigilância em Saúde do Amazonas - Dra Rosemary Costa Pinto, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundação Centro de Controle de Oncologia do Estado do Amazonas, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Costa</LastName><ForeName>Cristiano Fernandes</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Fundação de Vigilância em Saúde do Amazonas - Dra Rosemary Costa Pinto, Manaus, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Conselho de Secretários Municipais de Saúde do Amazonas COSEMS - AM, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdalla</LastName><ForeName>Ligia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universidade do Estado do Amazonas, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>João Hugo</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Hospital Adventista de Manaus, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>Tatyana Costa Amorim</ForeName><Initials>TCA</Initials><AffiliationInfo><Affiliation>Fundação de Vigilância em Saúde do Amazonas - Dra Rosemary Costa Pinto, Manaus, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piantham</LastName><ForeName>Chayada</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Graduate School of Infectious Diseases, Hokkaido University, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Kimihito</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>International Institute for Zoonosis Control, Hokkaido University, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Marilda Mendonça</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resende</LastName><ForeName>Paola Cristina</ForeName><Initials>PC</Initials><Identifier Source="ORCID">0000-0002-2884-3662</Identifier><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallau</LastName><ForeName>Gabriel Luz</ForeName><Initials>GL</Initials><Identifier Source="ORCID">0000-0002-1419-5713</Identifier><AffiliationInfo><Affiliation>Instituto Aggeu Magalhães, Fundação Oswaldo Cruz, Recife, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delatorre</LastName><ForeName>Edson</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Biologia, Centro de Ciências Exatas, Naturais e da Saúde, Universidade Federal do Espírito Santo, Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gräf</LastName><ForeName>Tiago</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratório de Virologia Molecular, Instituto Carlos Chagas, Fiocruz, Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naveca</LastName><ForeName>Felipe Gomes</ForeName><Initials>FG</Initials><Identifier Source="ORCID">0000-0002-2888-1060</Identifier><AffiliationInfo><Affiliation>Laboratório de Ecologia de Doenças Transmissíveis na Amazônia, Instituto Leônidas e Maria Deane, Fiocruz, Manaus, Brazil. felipe.naveca@fiocruz.br.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil. felipe.naveca@fiocruz.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37041143</ArticleId><ArticleId IdType="pmc">PMC10089528</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-37541-6</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-37541-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen Z, et al. Global landscape of SARS-CoV-2 genomic surveillance and data sharing. Nat. Genet. 2022;54:499–507. doi: 10.1038/s41588-022-01033-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01033-y</ArticleId><ArticleId IdType="pmc">PMC9005350</ArticleId><ArticleId IdType="pubmed">35347305</ArticleId></ArticleIdList></Reference><Reference><Citation>Telenti A, Hodcroft EB, Robertson DL. The evolution and biology of SARS-CoV-2 variants. Cold Spring Harb. Perspect. Med. 2022;12:a041390. doi: 10.1101/cshperspect.a041390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a041390</ArticleId><ArticleId IdType="pmc">PMC9159258</ArticleId><ArticleId IdType="pubmed">35444005</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana R, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022;603:679–686. doi: 10.1038/s41586-022-04411-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04411-y</ArticleId><ArticleId IdType="pmc">PMC8942855</ArticleId><ArticleId IdType="pubmed">35042229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tegally, H. et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat. Med.28, 1785–1790 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499863</ArticleId><ArticleId IdType="pubmed">35760080</ArticleId></ArticleIdList></Reference><Reference><Citation>Beesley, L. J. et al. SARS-CoV-2 variant transition dynamics are associated with vaccination rates, number of co-circulating variants, and convalescent immunity. EBioMedicine.91, 104534 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10065418</ArticleId><ArticleId IdType="pubmed">37004335</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura I, et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell. 2022;185:3992–4007.e16. doi: 10.1016/j.cell.2022.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.09.018</ArticleId><ArticleId IdType="pmc">PMC9472642</ArticleId><ArticleId IdType="pubmed">36198317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushman, M., Kahn, R., Taylor, B. P., Lipsitch, M. &amp; Hanage, W. P. Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape. Cell184, 6229–6242.e18 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8603072</ArticleId><ArticleId IdType="pubmed">34910927</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S. Hybrid immunity. Science. 2021;372:1392–1393. doi: 10.1126/science.abj2258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj2258</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi, R. &amp; Ott, M. SARS-CoV-2 hybrid immunity: silver bullet or silver lining? Nat. Rev. Immunol. 10.1038/s41577-022-00771-8 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362961</ArticleId><ArticleId IdType="pubmed">35945353</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreano E, et al. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants. Nature. 2021;600:530–535. doi: 10.1038/s41586-021-04117-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04117-7</ArticleId><ArticleId IdType="pmc">PMC8674140</ArticleId><ArticleId IdType="pubmed">34670266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates TA, et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci. Immunol. 2022;7:eabn8014. doi: 10.1126/sciimmunol.abn8014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abn8014</ArticleId><ArticleId IdType="pmc">PMC8939472</ArticleId><ArticleId IdType="pubmed">35076258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall V, et al. Protection against SARS-CoV-2 after covid-19 vaccination and previous infection. N. Engl. J. Med. 2022;386:1207–1220. doi: 10.1056/NEJMoa2118691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118691</ArticleId><ArticleId IdType="pmc">PMC8908850</ArticleId><ArticleId IdType="pubmed">35172051</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira-Silva T, et al. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. Lancet Infect. Dis. 2022;22:791–801. doi: 10.1016/S1473-3099(22)00140-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00140-2</ArticleId><ArticleId IdType="pmc">PMC8971277</ArticleId><ArticleId IdType="pubmed">35366959</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, et al. SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses. Cell. 2022;185:872–880.e3. doi: 10.1016/j.cell.2022.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.011</ArticleId><ArticleId IdType="pmc">PMC8769922</ArticleId><ArticleId IdType="pubmed">35123650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobrovitz, N. et al. Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis. S1473-3099(22)00801-5, 10.1016/S1473-3099(22)00801-5 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10014083</ArticleId><ArticleId IdType="pubmed">36681084</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P, et al. Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant. Science. 2021;374:eabl9551. doi: 10.1126/science.abl9551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl9551</ArticleId><ArticleId IdType="pmc">PMC10763627</ArticleId><ArticleId IdType="pubmed">34726481</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Shaman JL. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron) eLife. 2022;11:e78933. doi: 10.7554/eLife.78933.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.78933</ArticleId><ArticleId IdType="pmc">PMC9363123</ArticleId><ArticleId IdType="pubmed">35943138</ArticleId></ArticleIdList></Reference><Reference><Citation>Eales O, et al. Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England. Nat. Commun. 2022;13:4375. doi: 10.1038/s41467-022-32096-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32096-4</ArticleId><ArticleId IdType="pmc">PMC9330949</ArticleId><ArticleId IdType="pubmed">35902613</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P, et al. Rapid increase in Omicron infections in England during December 2021: REACT-1 study. Science. 2022;375:1406–1411. doi: 10.1126/science.abn8347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn8347</ArticleId><ArticleId IdType="pmc">PMC8939772</ArticleId><ArticleId IdType="pubmed">35133177</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveca FG, et al. COVID-19 in Amazonas, Brazil, was driven by the persistence of endemic lineages and P.1 emergence. Nat. Med. 2021;27:1230–1238. doi: 10.1038/s41591-021-01378-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01378-7</ArticleId><ArticleId IdType="pubmed">34035535</ArticleId></ArticleIdList></Reference><Reference><Citation>He, D. et al. The unexpected dynamics of COVID-19 in Manaus, Brazil: Was herd immunity achieved? Preprint at medRxiv10.1101/2021.02.18.21251809 (2021).</Citation></Reference><Reference><Citation>Buss LF, et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021;371:288–292. doi: 10.1126/science.abe9728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe9728</ArticleId><ArticleId IdType="pmc">PMC7857406</ArticleId><ArticleId IdType="pubmed">33293339</ArticleId></ArticleIdList></Reference><Reference><Citation>FVS. Portal Portal da Fundação de Vigilância em Saúde do Amazonas-RCP/AM. Vacinômetro COVID-19 Amazonas. https://www.fvs.am.gov.br/indicadorSalaSituacao_view/75/2 (2022).</Citation></Reference><Reference><Citation>Lamarca AP, et al. Genomic surveillance tracks the first community outbreak of the SARS-CoV-2 delta (B.1.617.2) variant in Brazil. J. Virol. 2022;96:e0122821. doi: 10.1128/JVI.01228-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01228-21</ArticleId><ArticleId IdType="pmc">PMC8791247</ArticleId><ArticleId IdType="pubmed">34730387</ArticleId></ArticleIdList></Reference><Reference><Citation>Arantes I, et al. Emergence and spread of the SARS-CoV-2 variant of concern Delta across different Brazilian regions. Microbiol. Spectr. 2022;10:e0264121. doi: 10.1128/spectrum.02641-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02641-21</ArticleId><ArticleId IdType="pmc">PMC9604183</ArticleId><ArticleId IdType="pubmed">36000897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito, K., Piantham, C. &amp; Nishiura, H. Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021. Eurosurveillance26, 2100570 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8268651</ArticleId><ArticleId IdType="pubmed">34240695</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, et al. Reproduction number of the omicron variant triples that of the delta variant. Viruses. 2022;14:821. doi: 10.3390/v14040821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040821</ArticleId><ArticleId IdType="pmc">PMC9027795</ArticleId><ArticleId IdType="pubmed">35458551</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Rocklöv J. The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. J. Travel Med. 2022;29:taac037. doi: 10.1093/jtm/taac037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taac037</ArticleId><ArticleId IdType="pmc">PMC8992231</ArticleId><ArticleId IdType="pubmed">35262737</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiura H, et al. Relative reproduction number of SARS-CoV-2 omicron (B.1.1.529) compared with delta variant in South Africa. J. Clin. Med. 2021;11:30. doi: 10.3390/jcm11010030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11010030</ArticleId><ArticleId IdType="pmc">PMC8745053</ArticleId><ArticleId IdType="pubmed">35011781</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito K, Piantham C, Nishiura H. Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark. Math. Biosci. Eng. 2022;19:9005–9017. doi: 10.3934/mbe.2022418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/mbe.2022418</ArticleId><ArticleId IdType="pubmed">35942746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito K, Piantham C, Nishiura H. Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark. J. Med. Virol. 2022;94:2265–2268. doi: 10.1002/jmv.27560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27560</ArticleId><ArticleId IdType="pmc">PMC9015237</ArticleId><ArticleId IdType="pubmed">34967453</ArticleId></ArticleIdList></Reference><Reference><Citation>Piantham, C. &amp; Ito, K. Predicting the Trajectory of Replacements of SARS-CoV-2 Variants Using Relative Reproduction Numbers. Viruses14, 2556 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9697243</ArticleId><ArticleId IdType="pubmed">36423165</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveca FG, et al. Spread of gamma (P.1) Sub-Lineages carrying spike mutations close to the furin cleavage site and deletions in the n-terminal domain drives ongoing transmission of SARS-CoV-2 in Amazonas, Brazil. Microbiol. Spectr. 2022;10:e0236621. doi: 10.1128/spectrum.02366-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02366-21</ArticleId><ArticleId IdType="pmc">PMC8865440</ArticleId><ArticleId IdType="pubmed">35196783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupferschmidt K, Wadman M. Delta variant triggers new phase in the pandemic. Science. 2021;372:1375–1376. doi: 10.1126/science.372.6549.1375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.372.6549.1375</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhar MS, et al. Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India. Science. 2021;374:995–999. doi: 10.1126/science.abj9932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj9932</ArticleId><ArticleId IdType="pmc">PMC7612010</ArticleId><ArticleId IdType="pubmed">34648303</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherian S, et al. SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India. Microorganisms. 2021;9:1542. doi: 10.3390/microorganisms9071542.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9071542</ArticleId><ArticleId IdType="pmc">PMC8307577</ArticleId><ArticleId IdType="pubmed">34361977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolze A, et al. SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loads. Cell Rep. Med. 2022;3:100564. doi: 10.1016/j.xcrm.2022.100564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100564</ArticleId><ArticleId IdType="pmc">PMC8922438</ArticleId><ArticleId IdType="pubmed">35474739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wadman, M. A grim warning from Israel: vaccination blunts, but does not defeat Delta. 10.1126/science.abl9630 (AAAS Articles DO Group, 2021).</Citation></Reference><Reference><Citation>Giovanetti M, et al. Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic. Virus Evol. 2022;8:veac024. doi: 10.1093/ve/veac024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac024</ArticleId><ArticleId IdType="pmc">PMC8971541</ArticleId><ArticleId IdType="pubmed">35371559</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca PLC, et al. Tracking the turnover of SARS-CoV-2 VOCs Gamma to Delta in a Brazilian state (Minas Gerais) with a high-vaccination status. Virus Evol. 2022;8:veac064. doi: 10.1093/ve/veac064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac064</ArticleId><ArticleId IdType="pmc">PMC9384558</ArticleId><ArticleId IdType="pubmed">35996592</ArticleId></ArticleIdList></Reference><Reference><Citation>Filho, T. R. et al. Attack rate and the price of SARS-CoV-2 herd immunity in Brazil. Preprint at 10.21203/rs.3.rs-659187/v2 (2021).</Citation></Reference><Reference><Citation>Barber RM, et al. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet. 2022;399:2351–2380. doi: 10.1016/S0140-6736(22)00484-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00484-6</ArticleId><ArticleId IdType="pmc">PMC8993157</ArticleId><ArticleId IdType="pubmed">35405084</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Rocklöv J. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. J. Travel Med. 2021;28:taab124. doi: 10.1093/jtm/taab124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taab124</ArticleId><ArticleId IdType="pmc">PMC8436367</ArticleId><ArticleId IdType="pubmed">34369565</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiori M, et al. Decoupling between SARS-CoV-2 transmissibility and population mobility associated with increasing immunity from vaccination and infection in South America. Sci. Rep. 2022;12:6874. doi: 10.1038/s41598-022-10896-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10896-4</ArticleId><ArticleId IdType="pmc">PMC9044384</ArticleId><ArticleId IdType="pubmed">35478213</ArticleId></ArticleIdList></Reference><Reference><Citation>Earnest R, et al. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. Cell Rep. Med. 2022;3:100583. doi: 10.1016/j.xcrm.2022.100583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100583</ArticleId><ArticleId IdType="pmc">PMC8913280</ArticleId><ArticleId IdType="pubmed">35480627</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira-Silva T, et al. Vaccination plus previous infection: protection during the omicron wave in Brazil. Lancet Infect. Dis. 2022;22:945–946. doi: 10.1016/S1473-3099(22)00288-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00288-2</ArticleId><ArticleId IdType="pmc">PMC9110013</ArticleId><ArticleId IdType="pubmed">35588753</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartha, F. A. et al. Potential Severity, Mitigation, and Control of Omicron Waves Depending on Pre-existing Immunity and Immune Evasion. In Trends in Biomathematics: Stability and Oscillations in Environmental, Social, and Biological Models. BIOMAT 2021. (ed. Mondaini, R. P.) (Springer, Cham., 2022). 10.1007/978-3-031-12515-7_22.</Citation></Reference><Reference><Citation>Washburne, A. D., Hupert, N., Kogan, N., Hanage, W. &amp; Santillana, M. Characterizing features of outbreak duration for novel SARS-CoV-2 variants of concern. Preprint at medRxiv10.1101/2022.01.14.22269288 (2022).</Citation></Reference><Reference><Citation>van Dorp, C., Goldberg, E., Ke, R., Hengartner, N. &amp; Romero-Severson, E. Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron. Virus Evol. 8, veac089 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9615435</ArticleId><ArticleId IdType="pubmed">36325031</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabowski F, Kochańczyk M, Lipniacki T. The spread of SARS-CoV-2 variant omicron with a doubling time of 2.0–3.3 days can be explained by immune evasion. Viruses. 2022;14:294. doi: 10.3390/v14020294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14020294</ArticleId><ArticleId IdType="pmc">PMC8875689</ArticleId><ArticleId IdType="pubmed">35215887</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard, R. C., Davies, N. G., Pearson, C. A. B., Jit, M. &amp; Edmunds, W. J. Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022. Preprint at medRxiv10.1101/2021.12.15.21267858 (2021).</Citation></Reference><Reference><Citation>Bager P, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: An observational cohort study. Lancet Infect. Dis. 2022;22:967–976. doi: 10.1016/S1473-3099(22)00154-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00154-2</ArticleId><ArticleId IdType="pmc">PMC9033212</ArticleId><ArticleId IdType="pubmed">35468331</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies M, et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Trop. Med. Int. Health. 2022;27:564–573. doi: 10.1111/tmi.13752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tmi.13752</ArticleId><ArticleId IdType="pmc">PMC9115442</ArticleId><ArticleId IdType="pubmed">35411997</ArticleId></ArticleIdList></Reference><Reference><Citation>Nealon J, Cowling BJ. Omicron severity: milder but not mild. Lancet. 2022;399:412–413. doi: 10.1016/S0140-6736(22)00056-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00056-3</ArticleId><ArticleId IdType="pmc">PMC8769661</ArticleId><ArticleId IdType="pubmed">35065007</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnaout R, Arnaout R. Visualizing omicron: COVID-19 deaths vs. cases over time. PLoS ONE. 2022;17:e0265233. doi: 10.1371/journal.pone.0265233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265233</ArticleId><ArticleId IdType="pmc">PMC9017933</ArticleId><ArticleId IdType="pubmed">35439253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg T, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399:1303–1312. doi: 10.1016/S0140-6736(22)00462-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId><ArticleId IdType="pmc">PMC8926413</ArticleId><ArticleId IdType="pubmed">35305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksamentov I, Roemer C, Hodcroft E, Neher R. Nextclade: Clade assignment, mutation calling and quality control for viral genomes. J. Open-Source Softw. 2021;6:3773. doi: 10.21105/joss.03773.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.03773</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Toole, Á. et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 10.1093/ve/veab064 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8344591</ArticleId><ArticleId IdType="pubmed">34527285</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S, et al. GISAID’s role in pandemic response. China CDC Wkly. 2021;3:1049–1051. doi: 10.46234/ccdcw2021.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.255</ArticleId><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J. Mol. Biol. 1990;215:403–410. doi: 10.1016/S0022-2836(05)80360-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-2836(05)80360-2</ArticleId><ArticleId IdType="pubmed">2231712</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 2013;30:772–780. doi: 10.1093/molbev/mst010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mst010</ArticleId><ArticleId IdType="pmc">PMC3603318</ArticleId><ArticleId IdType="pubmed">23329690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 2014;32:268–274. doi: 10.1093/molbev/msu300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msu300</ArticleId><ArticleId IdType="pmc">PMC4271533</ArticleId><ArticleId IdType="pubmed">25371430</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat. Methods. 2017;14:587–589. doi: 10.1038/nmeth.4285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4285</ArticleId><ArticleId IdType="pmc">PMC5453245</ArticleId><ArticleId IdType="pubmed">28481363</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A, Lam TT, Max Carvalho L, Pybus OG. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen) Virus Evol. 2016;2:vew007. doi: 10.1093/ve/vew007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vew007</ArticleId><ArticleId IdType="pmc">PMC4989882</ArticleId><ArticleId IdType="pubmed">27774300</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchene S, et al. Temporal signal and the phylodynamic threshold of SARS-CoV-2. Virus Evol. 2020;6:veaa061. doi: 10.1093/ve/veaa061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veaa061</ArticleId><ArticleId IdType="pmc">PMC7454936</ArticleId><ArticleId IdType="pubmed">33235813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghafari M, et al. Purifying selection determines the short-term time dependency of evolutionary rates in SARS-CoV-2 and pH1N1 influenza. Mol. Biol. Evol. 2022;39:msac009. doi: 10.1093/molbev/msac009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msac009</ArticleId><ArticleId IdType="pmc">PMC8826518</ArticleId><ArticleId IdType="pubmed">35038728</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay JH, Porter AF, Wirth W, Duchene S. The emergence of SARS-CoV-2 variants of concern is driven by acceleration of the substitution rate. Mol. Biol. Evol. 2022;39:msac013. doi: 10.1093/molbev/msac013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msac013</ArticleId><ArticleId IdType="pmc">PMC8807201</ArticleId><ArticleId IdType="pubmed">35038741</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol. 2018;4:vey016. doi: 10.1093/ve/vey016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vey016</ArticleId><ArticleId IdType="pmc">PMC6007674</ArticleId><ArticleId IdType="pubmed">29942656</ArticleId></ArticleIdList></Reference><Reference><Citation>Drummond AJ. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 2005;22:1185–1192. doi: 10.1093/molbev/msi103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msi103</ArticleId><ArticleId IdType="pubmed">15703244</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A, Drummond AJ, Xie D, Baele G, Suchard MA. Posterior summarization in Bayesian phylogenetics using tracer 1.7. Syst. Biol. 2018;67:901–904. doi: 10.1093/sysbio/syy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sysbio/syy032</ArticleId><ArticleId IdType="pmc">PMC6101584</ArticleId><ArticleId IdType="pubmed">29718447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemey P, Rambaut A, Drummond AJ, Suchard MA. Bayesian phylogeography finds its roots. PLoS Comput. Biol. 2009;5:e1000520. doi: 10.1371/journal.pcbi.1000520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1000520</ArticleId><ArticleId IdType="pmc">PMC2740835</ArticleId><ArticleId IdType="pubmed">19779555</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Brien JD, Minin VN, Suchard MA. Learning to count: robust estimates for labeled distances between molecular sequences. Mol. Biol. Evol. 2009;26:801–814. doi: 10.1093/molbev/msp003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msp003</ArticleId><ArticleId IdType="pmc">PMC2734148</ArticleId><ArticleId IdType="pubmed">19131426</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunson J. ggalluvial: layered grammar for alluvial plots. J. Open Source Softw. 2020;5:2017. doi: 10.21105/joss.02017.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.02017</ArticleId><ArticleId IdType="pmc">PMC10010671</ArticleId><ArticleId IdType="pubmed">36919162</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2016).</Citation></Reference><Reference><Citation>Hart WS, et al. Generation time of the alpha and delta SARS-CoV-2 variants: an epidemiological analysis. Lancet Infect. Dis. 2022;22:603–610. doi: 10.1016/S1473-3099(22)00001-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00001-9</ArticleId><ArticleId IdType="pmc">PMC8843191</ArticleId><ArticleId IdType="pubmed">35176230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawitan, Y. In all Likelihood: Statistical Modelling and Inference Using Likelihood (Oxford University Press, 2013).</Citation></Reference><Reference><Citation>Stadler T, Kühnert D, Bonhoeffer S, Drummond AJ. Birth–death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV) Proc. Natl Acad. Sci. USA. 2012;110:228–233. doi: 10.1073/pnas.1207965110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207965110</ArticleId><ArticleId IdType="pmc">PMC3538216</ArticleId><ArticleId IdType="pubmed">23248286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouckaert R, et al. BEAST 2.5: an advanced software platform for Bayesian evolutionary analysis. PLOS Comput. Biol. 2019;15:e1006650. doi: 10.1371/journal.pcbi.1006650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1006650</ArticleId><ArticleId IdType="pmc">PMC6472827</ArticleId><ArticleId IdType="pubmed">30958812</ArticleId></ArticleIdList></Reference><Reference><Citation>Google. COVID-19 community mobility reports. COVID-19 Community Mobility Report. https://www.google.com/covid19/mobility/ (2022).</Citation></Reference><Reference><Citation>Cota, W. Monitoring the number of COVID-19 cases and deaths in Brazil at municipal and federative units level. 10.1590/scielopreprints.362 (FapUNIFESP (SciELO), 2020).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>